Login / Signup
[Systemic Inflammatory Markers Can Improve Survival Prediction of Patients with Diffuse Large B-Cell Lymphoma: Model Development and Evaluation].
Ya-Jiao Liu
Li Sheng
Jing-Fen Zhou
Hai-Ying Hua
Published in:
Zhongguo shi yan xue ye xue za zhi (2024)
The nomogram combined with inflammatory indicators can accurately predict the individual survival probability of DLBCL patients.
Keyphrases
</>
diffuse large b cell lymphoma
epstein barr virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
oxidative stress
patient reported outcomes